focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Mine is:
13-Dec-23 11:39:55 1.5186 500,985 Unknown* showing in black.
Well done for your super cheap buys. Very jealous but well deserved.
I had a feeling them sells where buys. Great entry
Bought in with over £7k worth for the good start
An early show of hands, Genflow next ??? Gla ;-)
Extended Longevity Enters XPRIZE Healthspan Competition with Groundbreaking Anti-Aging Solutions
December 12, 2023 10:08 AM Eastern Standard Time
KULA, Hawaii--(BUSINESS WIRE)--Extended Longevity, a pioneering company in the field of longevity and anti-aging, is proud to announce its entry into the prestigious $101 million dollar XPRIZE Healthspan competition. This move marks a significant milestone in Extended Longevity's commitment to revolutionize the way we understand and approach aging.
htTps://www.businesswire.com/news/home/20231212060240/en/Extended-Longevity-Enters-XPRIZE-Healthspan-Competition-with-Groundbreaking-Anti-Aging-Solutions
A truly mouth watering list of potential news flow!
So many things that could be our next bout of news:
- XPrize submission
- Funding updates
- Confirmation of grant money received committed early on in year
- New pipelines
- Parties interested in buy out expressing formal interest
- Formal takeover offers submitted
- Trial results
- Ageing being recognised as a disease
- More experts joining the board and team
- New collaborative partnerships
- Patents approved
- New patents submitted
List continues…
I believe this would see the SP back to 5p alone.
Lol Northeast, I should very much think so, inbthat Genflow have highlited it twice in the last week on Linkden, although plenty of other grants/funding/investments just as likely from those who can see the bigger picture...Excitement building....Ho ho ho :-)
GenFlow Biosciences
1,347 followers
5d
The XPRIZE Healthspan competition is a 7-year, $101 million global contest aimed at revolutionizing human aging. It focuses on creating proactive, accessible therapies that reduce the risk of chronic age-related diseases, improve healthspan, and extend quality of life into later years. The competition seeks to shift from traditional medicine's reactive approach to a more proactive one, aiming to improve overall health quality and reduce healthcare costs associated with aging. For more details: https://loom.ly/6xVoHz0 #XPRIZE #healthspan #longevity #genetherapy
Could we potentially be away to enter into the $101 million dollar XPRIZE Healthspan competition?
Ps I reckon Eric has news up his sleeve. GLA :-)
"Genflow is at the forefront with our promising GF-1002 treatment, showcasing adipogenic, anti-fibrotic, and anti-tumoral effects. This progress is significant in a market expected to reach $27.2B by 2029."
2024 will be our year.
Amazing what positive Phase 2 results can do. Gla :-)
https://longevity.technology/news/eyepoint-raises-230-million-following-positive-amd-trial-results/amp/
GenFlow Biosciences
1,347 followers
2h
A recent Fierce Pharma article highlights the burgeoning market for NASH (Non-Alcoholic Steatohepatitis) treatments, a crucial area where GenFlow Biosciences (LSE: GENF)(OTCQB: GENFF) is actively contributing. As the NASH patient population rapidly grows, the need for effective therapies becomes increasingly urgent. Genflow is at the forefront with our promising GF-1002 treatment, showcasing adipogenic, anti-fibrotic, and anti-tumoral effects. This progress is significant in a market expected to reach $27.2B by 2029. We're proud to contribute to a future where NASH patients have hope for better treatments. Read more: https://loom.ly/tjXfrkE Discover more about our clinical programs: https://loom.ly/kKTAoxM #GenflowBiosciences #NASH #livertreatment
I’d be proper devastated if I sold my shares for 1.5p, only for Eric to get that patent fully approved and Astra to come along and offer £3 a share. Saying that, I’ve enjoyed these lows, as it’s allowed me to increase my holding. One’s loss, is another’s gain.
Loads of reasons why a few punters might want sell out at this time of year, and you have to feel for those who had been selling out at the rockbottom low at DGI , prior to their news....Gla holders!!! :-)
At these levels it’s got to be people who got the shares for free at the very beginning or who got in extremely cheap and want out. Let them out and we move on
GLA
Sadly a number still exiting..! something is not making sense??? Any ideas??
Lots happening. Those who truly believe will be here till the end.
GLA
Hopefully so Porter, and 2024 could be a stellar year for all invested. In the meantime more compelling research on Sirt6, hot off the press. Gl :-)
https://www.lifespan.io/news/repairing-dna-with-sirtuins-for-arthritis/
Certainly some amazing work going on there to report on Munch!
The longer for news the better for me as I have been adding at these levels whenever my wages come in.
We will hopefully be able to open a bottle of bubbly thanks to Genflow before Xmas! 🎄
C'mon Eric, any news for Christmas as news on lgrants/funding were expected soon along with 4 final invivo studies from Genflows High profile academic collaborations....news of a Major investor and or JV partner highly possible at anytime. :-)
28/9/23
The Company continues to maintain a secure financial position and has sufficient cash reserves until March 2025. This is inclusive of grant funding which has been approved at the time of reporting and is due to be received in the coming months. The Company continues to seek further non-dilutive research grants which management will use to expedite specific phases of planned research and development.
......
The Company is conducting in-vivo evaluations of its centenarian SIRT6 gene therapy in four different NASH mice models in conjunction with four leading partners in the field: The University of Liverpool, UK, The University of Rochester, US, the International Clinical Research Center (FNUSA-ICRC) , Czech Republic and Physiogenex, France.
These studies have been wide reaching and have included the analysation of over 700 mice, with the intention of understanding the efficacy and safety of the Company's drug candidate in animal models with NASH and has generated essential information in preparation for clinical trials in humans. Final reports are expected by the end of 2023.
Apologies, wrong board.
Down 17% Jesus Christ.
That's certainly from one trader today.
Maybe the last of the moronic selling at record lows?
Getting hard to see is this.
And also would be good to see the other directors (excluding CEO) to buy in at such levels.. I am sure some of us are holding more than them!!